Search hospitals > California > Los Angeles
The Angeles Clinic and Research Institute
Claim this profileLos Angeles, California 90025
Global Leader in Skin Cancer
Global Leader in Melanoma
Conducts research for Uterine Tumors
Conducts research for Solid Tumors
Conducts research for Cancer
111 reported clinical trials
9 medical researchers
Summary
The Angeles Clinic and Research Institute is a medical facility located in Los Angeles, California. This center is recognized for care of Skin Cancer, Melanoma, Uterine Tumors, Solid Tumors, Cancer and other specialties. The Angeles Clinic and Research Institute is involved with conducting 111 clinical trials across 103 conditions. There are 9 research doctors associated with this hospital, such as Omid Hamid, Navid Hafez, MD, Inderjit Mehmi, MD, and Vi K Chiu.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
BRAF positive
2Melanoma
Global LeaderStage IV
Stage III
BRAF positive
Top PIs
Omid HamidThe Angeles Clinic and Research Institute3 years of reported clinical research
Expert in Skin Cancer
Studies Melanoma
24 reported clinical trials
63 drugs studied
Navid Hafez, MDYale University7 years of reported clinical research
Expert in Uterine Tumors
Studies Cancer
13 reported clinical trials
34 drugs studied
Inderjit Mehmi, MDThe Angeles Clinic and Research Institute3 years of reported clinical research
Studies Melanoma
Studies Skin Cancer
9 reported clinical trials
12 drugs studied
Vi K ChiuThe Angeles Clinic and Research Institute3 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
6 reported clinical trials
16 drugs studied
Clinical Trials running at The Angeles Clinic and Research Institute
Skin Cancer
Solid Tumors
Cancer
Lung Cancer
Ovarian Cancer
Uterine Tumors
Melanoma
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Endometrial Cancer
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
VO + Nivolumab
for Advanced Melanoma
This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment for patients with unresectable Stage IIIb-IV cutaneous melanoma whose disease progressed on an anti PD-1 and an anti-CTLA-4 containing regimen (administered either as a combination regimen or in sequence) or who are not candidates for treatment with an anti-CTLA-4 therapy.
Recruiting2 awards Phase 33 criteria
Biomarker-Guided Immunotherapy Discontinuation
for Melanoma
This trial uses drugs that boost the immune system to fight advanced melanoma that can't be surgically removed. It aims to see if doctors can safely shorten the treatment period by using imaging tests to guide decisions. Pembrolizumab and ipilimumab are immunotherapy drugs used to treat advanced melanoma, with pembrolizumab approved for younger patients and ipilimumab showing positive results in previous studies.
Recruiting1 award Phase 222 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Angeles Clinic and Research Institute?
The Angeles Clinic and Research Institute is a medical facility located in Los Angeles, California. This center is recognized for care of Skin Cancer, Melanoma, Uterine Tumors, Solid Tumors, Cancer and other specialties. The Angeles Clinic and Research Institute is involved with conducting 111 clinical trials across 103 conditions. There are 9 research doctors associated with this hospital, such as Omid Hamid, Navid Hafez, MD, Inderjit Mehmi, MD, and Vi K Chiu.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.